Summary
Webinar Link
During this webinar, presenters will look at surgeon readiness for operating following neoadjuvant immunotherapy and targeted therapies, while sharing new knowledge of pathology review and standardized assessment of pathologic complete response (pCR). The program reinforces the rationale for adjuvant therapy continuation, drawing on evidence from AEGEAN, including event-free survival outcomes, pathology-linked insights, and postoperative treatment sequencing. The session also defines the surgeon’s role in educating patients across the full treatment journey.
Supported by AstraZeneca.
Speakers
Douglas Liou, MD
Stanford University
Stanford, CA
Jacobi B. Hines, MD
Northwestern University
Chicago, IL
